Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators

Kidney International

Volumn 68, Issue 2, 2005, Pages 818-825

  Herzog, Charles A ^a   Li, Shuling ^b   Weinhandl, Eric D ^b   Strief, Jeremy W ^b   Collins, Allan J ^b   Gilbertson, David T ^b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b NONE

Author keywords

Cardiac arrest; Defibrillation; Dialysis; Survival

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DEATH; DEFIBRILLATOR; DIALYSIS; FEMALE; HEART ARREST; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; IMPLANTATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; STATISTICAL MODEL; SURVIVAL; SURVIVAL TIME; CHRONIC KIDNEY FAILURE; MIDDLE AGED; MORTALITY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; STATISTICS;

ADULT; AGED; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART ARREST; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; SURVIVAL ANALYSIS; VENTRICULAR FIBRILLATION;

EID: 26944454055     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00462.x     Document Type: Editorial

References (24)

1. U.S. RENAL DATA SYSTEM: USRDS 2003 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
2. HERZOG CA, MA JZ, COLLINS AJ: Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 339:799-805, 1998
3. U.S. RENAL DATA SYSTEM: USRDS 2004 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004
4. U.S. RENAL DATA SYSTEM: USRDS 2002 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002
5. AMANN K, RYCHLIK I, MILTENBERGER-MILTENY G, RITZ E: Left ventricular hypertrophy in renal failure. Kidney Int 68:S78-S85, 1998
6. AMANN K, RITZ E: Cardiac disease in chronic uremia: pathophysiology. Adv Renal Replace Ther 4:212-224, 1997
7. RITZ E, AMANN K, TORNIG J, et al: Some cardiac abnormalities in renal failure. Adv Nephrol Necker Hosp 27:85-103, 1997
8. AMANN K, BUZELLO M, SIMONAVICIENE A, et al: Capillary/myocyte mismatch in the heart in renal failure-a role for erythropoietin? Nephrol Dial Transplant 15:964-969, 2000
9. THE ANTIARRHYTHMICS VERSUS IMPLANTABLE DEFIBRILLATORS (AVID) INVESTIGATORS: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576-1583, 1997
10. KUCK KH, CAPPATO R, SIEBELS J, RUPPEL R: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 102:748-754, 2000
11. CONNOLLY SJ, GENT M, ROBERTS RS, et al: Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297-1302, 2000
12. CONNOLLY SJ, HALLSTROM AP, CAPPATO R, et al: Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies, Antiarrhythmics vs Implantable Defibrillator Study, Cardiac Arrest Study Hamburg, Canadian Implantable Defibrillator Study. Eur Heart J 21:2071-2078, 2000
13. COLLINS AJ, MA J, CONSTANTINI E, EVERSON S: Dialysis unit and patient characteristics associated with reuse practices and mortality: 1989-1993. J Am Soc Nephrol 9:2108-2117, 1998
14. ROSENBAUM PR, RUBIN DB: The central role of the propensity score in observational studies for causal effects. Biometrika 70:41-55, 1983
15. VOIGT A, EZZEDDINE R, BARRINGTON W, et al: Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol 44:855-858, 2004
16. BERGER AK, DUVAL S, KRUMHOLZ HM: Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 42:201-208, 2003
17. WRIGHT RS, REEDER GS, HERZOG CA, et al: Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137:563-570, 2002
18. SHLIPAK MG, HEIDENREICH PA, NOGUCHI H, et al: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137:555-562, 2002
19. BEATTIE JN, SOMAN SS, SANDBERG KR, et al: Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37:1191-1200, 2001
20. MCCULLOUGH PA, SANDBERG KR, BORZAK S, et al: Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 144:226-232, 2002
21. HERZOG CA: Cardiovascular disease and dialysis patients: Is therapeutic nihilism justified? Semin Dial 12:285-287, 1999
22. GREGORATOS G, ABRAMS J, EPSTEIN AE, et al: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol 13:1183-1199, 2002
23. KARNIK JA, YOUNG BS, LEW NL, et al: Cardiac arrest and sudden death in dialysis units. Kidney Int 60:350-357, 2001
24. BECKER L, EISENBERG M, FAHRENBRUCH C, COBB L: Cardiac arrest in medical and dental practices: Implications for automated external defibrillators. Arch Intern Med 161:1509-1512, 2001